- Quote, Chart, News
- Snapshot
- Company Report
- Quotes
- Charts
- Key Developments
Recent News- Research
- SEC Filings
- Advisor FYI
- CAPS
- StockScouter
- Earnings Estimates
- Analyst Ratings
- Financial Results
- Insider Trading
- Ownership
- Message Board
- Guided Research
- Research Wizard
- Find Stocks
- Stock Screener
- Stock Power Searches
- Top-Rated Stocks
- Related Links
- Quote Watchlist
- Expert Picks
- E-mail & Alerts
- IPO Center
- Message Boards
- Capital Gains Analysis
News resources
| Citigroup Inc (C) | 11 stories... |
| Wal-Mart Stores Inc (WMT) | 9 stories... |
| Medtronic Inc (MDT) | 8 stories... |
| Warner Music Group Corp (WMG) | 7 stories... |
| Bank of America Corp (BAC) | 6 stories... |
| advertisement |
Roche Holding 144A ADR: All Recent News
- 454 Life Sciences Unveils New Bench Top Sequencer, Significant... 11/19/2009
- 454 Life Sciences, a Roche Company (SWX:RO) (SWX:ROG) (Pink Sheets: RHHBY), announced today at the Association of Molecular Pathology Annual Meeting in Kissimmee, Florida a series of revolutionary... Business Wire
- New Cancer Research Tool: Roche’s CIM-Plate 16 Enables... 11/18/2009
- Roche Applied Science (Pink Sheets: RHHBY) (SWX:RO) (SWX:ROG) announces the availability of the new CIM-Plate 16 for their xCELLigence System for cell analysis, for use in cancer research. The... Business Wire
- Eurofins MWG Operon Joins Roche NimbleGen’s Certified Service... 11/17/2009
- Roche NimbleGen (SWX:RO) (SWX:ROG) (Pink Sheets: RHHBY) is pleased to announce that Eurofins MWG Operon, an Ebersberg, Germany-based company, has officially become a Certified Service Provider (CSP)... Business Wire
- Roche unit files for 2 FDA clearances for Avastin 11/17/2009
- TEL AVIV (MarketWatch) -- The Genentech subsidiary of Roche , the Basel health-care giant, said on Tuesday that it submitted to the U.S. Food and Drug Administration two applications to market Avastin to treat women who have not received chemotherapy for advanced HER2-negative breast cancer. The supplemental Biologics License Applications concern Avastin, generically bevacizumab, combined with two commonly used chemotherapies. One is docetaxel; the other envisions Avastin combined with a taxane, anthracycline-based or capecitabine chemotherapy. The studies that looked at Avastin combined with... At MarketWatch
- FDA Grants Emergency Use Authorization to Roche´s Assay for... 11/16/2009
- Roche`s (SWX:RO) (SWX:ROG) (Pink Sheets: RHHBY) RealTime ready Influenza A/H1N1 Detection Set for the 2009 H1N1 influenza virus has received emergency use authorization (EUA) from the U.S. Food and... Business Wire
- Researchers Use 454 Sequencing System to Complete Draft Genome... 11/10/2009
- A team of academic, government and industry researchers has completed a first draft of the cassava (Manihot esculenta) genome. The project is an important first step in accelerating the pace of... Business Wire
- South Korean FDA Probes Roche for Aiding Tamiflu Stockpiling 11/6/2009
- ... At Wall Street Journal
- Roche NimbleGen Arrays Help Unveil the Secrets of Insidious... 11/3/2009
- A large international team of researchers recently published the 240-megabase DNA sequence of Phytophthora infestans, a robust parasitic water mold responsible for the Irish potato famine of the... Business Wire
- Roche Applied Science Announces CGX Arrays Designed by... 11/2/2009
- Roche Applied Science (SWX:RO) (SWX:ROG) (Pink Sheets: RHHBY) will announce the European and Asia Pacific launch of the NimbleGen CGX arrays for microarray-based cytogenetic analysis at a workshop... Business Wire
- Norwegian Team Completes Cod Genome Using 454 Sequencing System 10/29/2009
- Scientist from a consortium of Norwegian marine and aquaculture institutions announced this week that they have generated the first ever draft sequence and assembly of the Atlantic cod genome. The... Business Wire
- Roche Molecular Systems Research Team Uses 454 Sequencing... 10/27/2009
- A study published this month in the journal Tissue Antigens reports that researchers at Roche Molecular Systems (SWX:RO) (SWX:ROG) (Pink Sheets: RHHBY) in Pleasanton, CA have used high-throughput... Business Wire
- Analysis of RNA Polymerase II Mutants using Roche´s... 10/22/2009
- The C-terminal domain (CTD) of RNA Polymerase II consists of multiple repeats of an evolutionary conserved motif of seven amino acids, forming a repetitive structure of 52 repeats in humans and 26... Business Wire
- Roche and High Throughput Genomics Partner for Advanced Gene... 10/20/2009
- Roche NimbleGen (SWX:RO)(SWX:ROG)(Pink Sheets:RHHBY) and High Throughput Genomics, Inc. (HTG), provider of the quantitative Nuclease Protection Assay (qNPA), have entered into a supply agreement. Business Wire
- DNA Link Announced as Roche NimbleGen’s First Certified... 10/14/2009
- Roche NimbleGen, a Roche Company (SWX:RO) (SWX:ROG) (Pink Sheets: RHHBY), has announced the first Certified Service Provider (CSP), DNA Link, Inc., who will provide service in Korea for NimbleGen... Business Wire
- Landmark Genotyping Study Demonstrates the Power of 454... 10/13/2009
- A study published online today in the prestigious Nature Medicine journal reports that researchers at the Wisconsin National Primate Research Center have explored a new high-throughput method for... Business Wire
- More News
- Market Report
- News by Symbol
- Today's Investing Articles
- Breaking News
- News by Topic
- News by Industry
- MSNBC News
- Data providers
- Copyright © 2009 Thomson Reuters. Click for Restrictions.
- Quotes supplied by Interactive Data Real-Time Services.